Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee. more
Time Frame | CPIX | Sector | S&P500 |
---|---|---|---|
1-Week Return | 12.66% | 0.31% | -1.26% |
1-Month Return | 25.94% | 0.6% | -4.16% |
3-Month Return | 103.82% | -9.44% | -0.46% |
6-Month Return | 82.88% | -5.15% | 3.58% |
1-Year Return | 36.92% | 0.33% | 22.47% |
3-Year Return | -33.08% | 4.53% | 25.13% |
5-Year Return | -47.95% | 35.98% | 77.7% |
10-Year Return | -55.13% | 100.72% | 190.12% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 34.39M | 37.44M | 35.99M | 42.01M | 39.55M | [{"date":"2019-12-31","value":81.86,"profit":true},{"date":"2020-12-31","value":89.12,"profit":true},{"date":"2021-12-31","value":85.66,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":94.15,"profit":true}] |
Cost of Revenue | 7.42M | 8.65M | 8.81M | 9.12M | 6.07M | [{"date":"2019-12-31","value":81.39,"profit":true},{"date":"2020-12-31","value":94.89,"profit":true},{"date":"2021-12-31","value":96.63,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":66.53,"profit":true}] |
Gross Profit | 26.97M | 28.79M | 27.17M | 32.89M | 33.49M | [{"date":"2019-12-31","value":80.53,"profit":true},{"date":"2020-12-31","value":85.97,"profit":true},{"date":"2021-12-31","value":81.15,"profit":true},{"date":"2022-12-31","value":98.23,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 78.42% | 76.89% | 75.51% | 78.29% | 84.66% | [{"date":"2019-12-31","value":92.63,"profit":true},{"date":"2020-12-31","value":90.82,"profit":true},{"date":"2021-12-31","value":89.19,"profit":true},{"date":"2022-12-31","value":92.48,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Expenses | 36.26M | 35.17M | 34.85M | 38.60M | 43.04M | [{"date":"2019-12-31","value":84.23,"profit":true},{"date":"2020-12-31","value":81.71,"profit":true},{"date":"2021-12-31","value":80.97,"profit":true},{"date":"2022-12-31","value":89.68,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (9.29M) | (6.38M) | (7.68M) | (5.70M) | (6.21M) | [{"date":"2019-12-31","value":-928818200,"profit":false},{"date":"2020-12-31","value":-638159500,"profit":false},{"date":"2021-12-31","value":-767742000,"profit":false},{"date":"2022-12-31","value":-570492900,"profit":false},{"date":"2023-12-31","value":-621081900,"profit":false}] |
Total Non-Operating Income/Expense | (5.64K) | (376.56K) | 2.04M | (363.85K) | (491.15K) | [{"date":"2019-12-31","value":-0.28,"profit":false},{"date":"2020-12-31","value":-18.43,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-17.81,"profit":false},{"date":"2023-12-31","value":-24.04,"profit":false}] |
Pre-Tax Income | (9.29M) | (6.57M) | (5.56M) | (5.58M) | (6.28M) | [{"date":"2019-12-31","value":-929100400,"profit":false},{"date":"2020-12-31","value":-656987700,"profit":false},{"date":"2021-12-31","value":-556223000,"profit":false},{"date":"2022-12-31","value":-558118900,"profit":false},{"date":"2023-12-31","value":-628499700,"profit":false}] |
Income Taxes | (79.32K) | 55.90K | 34.89K | 68.85K | 45.77K | [{"date":"2019-12-31","value":-115.2,"profit":false},{"date":"2020-12-31","value":81.19,"profit":true},{"date":"2021-12-31","value":50.68,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":66.48,"profit":true}] |
Income After Taxes | (9.21M) | (6.63M) | (5.60M) | (5.65M) | (6.33M) | [{"date":"2019-12-31","value":-921168800,"profit":false},{"date":"2020-12-31","value":-662577900,"profit":false},{"date":"2021-12-31","value":-559712100,"profit":false},{"date":"2022-12-31","value":-565003900,"profit":false},{"date":"2023-12-31","value":-633076600,"profit":false}] |
Income From Continuous Operations | (3.55M) | (6.63M) | (5.60M) | (5.65M) | (2.49M) | [{"date":"2019-12-31","value":-354651100,"profit":false},{"date":"2020-12-31","value":-662577900,"profit":false},{"date":"2021-12-31","value":-559712100,"profit":false},{"date":"2022-12-31","value":-565003900,"profit":false},{"date":"2023-12-31","value":-248849300,"profit":false}] |
Income From Discontinued Operations | 3.21M | 3.21M | 1.99M | - | - | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":62.19,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (9.21M) | (6.63M) | (5.60M) | (5.65M) | (6.28M) | [{"date":"2019-12-31","value":-921168800,"profit":false},{"date":"2020-12-31","value":-662577900,"profit":false},{"date":"2021-12-31","value":-559712100,"profit":false},{"date":"2022-12-31","value":-565003900,"profit":false},{"date":"2023-12-31","value":-627932000,"profit":false}] |
EPS (Diluted) | 0.31 | 0.12 | (0.18) | (0.26) | (0.15) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":38.71,"profit":true},{"date":"2021-12-31","value":-58.06,"profit":false},{"date":"2022-12-31","value":-83.87,"profit":false},{"date":"2023-12-31","value":-49.71,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
CPIX | |
---|---|
Cash Ratio | 0.56 |
Current Ratio | 1.13 |
Quick Ratio | 0.99 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
CPIX | |
---|---|
ROA (LTM) | -5.64% |
ROE (LTM) | -36.07% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
CPIX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.68 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.32 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
CPIX | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.89 |
P/B | 1.32 |
Price/FCF | 75 |
EV/R | 1.00 |
EV/Ebitda | 106.32 |
PEG | NM |
Cumberland Pharmaceuticals Inc (CPIX) share price today is $2.67
Yes, Indians can buy shares of Cumberland Pharmaceuticals Inc (CPIX) on Vested. To buy Cumberland Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CPIX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Cumberland Pharmaceuticals Inc (CPIX) via the Vested app. You can start investing in Cumberland Pharmaceuticals Inc (CPIX) with a minimum investment of $1.
You can invest in shares of Cumberland Pharmaceuticals Inc (CPIX) via Vested in three simple steps:
The 52-week high price of Cumberland Pharmaceuticals Inc (CPIX) is $3.05. The 52-week low price of Cumberland Pharmaceuticals Inc (CPIX) is $1.04.
The price-to-earnings (P/E) ratio of Cumberland Pharmaceuticals Inc (CPIX) is
The price-to-book (P/B) ratio of Cumberland Pharmaceuticals Inc (CPIX) is 1.32
The dividend yield of Cumberland Pharmaceuticals Inc (CPIX) is 0.00%
The market capitalization of Cumberland Pharmaceuticals Inc (CPIX) is $37.49M
The stock symbol (or ticker) of Cumberland Pharmaceuticals Inc is CPIX